Investment Management of Virginia’s Haemonetics HAE Stock Holding History

Investment Management of Virginia’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-11,271	Closed	-$825K	–	145
2018 Q1	$825K	Sell	11,271 -10,700	-49%	-$734K	0.19%	119
2017 Q4	$1.28M	Sell	21,971 -2,304	-9%	-$121K	0.3%	96
2017 Q3	$1.09M	Sell	24,275 -503	-2%	-$20.9K	0.26%	107
2017 Q2	$978K	Sell	24,778 -559	-2%	-$23K	0.24%	111
2017 Q1	$1.03M	Sell	25,337 -197	-0.8%	-$7.69K	0.25%	109
2016 Q4	$1.03M	Sell	25,534 -1,503	-6%	-$56.7K	0.25%	108
2016 Q3	$979K	Buy	+27,037	New	+$928K	0.24%	106

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Investment Management of Virginia's HAE Position: Q2 2018 in Review

Investment Management of Virginia sold out of Haemonetics (HAE) in Q2 2018, closing a stake of 11,271 shares — an estimated $825K sold.

Investment Management of Virginia first reported a position in HAE in Q3 2016 and held it in 7 quarters. The position peaked at $1.28M in Q4 2017. 293 funds tracked by Wall St. Rank hold HAE as of Q2 2018.

Investment Management of Virginia reported no remaining Haemonetics position as of Q2 2018 after selling out during the quarter.
Investment Management of Virginia sold 11,271 Haemonetics shares in Q2 2018, an estimated $825K.
Investment Management of Virginia first reported a position in Haemonetics in Q3 2016 and held it in 7 quarters.
Investment Management of Virginia's Haemonetics position peaked at $1.28M in Q4 2017.
293 funds tracked by Wall St. Rank held Haemonetics as of Q2 2018.

Based on Investment Management of Virginia's 13F filing for Q2 2018, filed 6 Aug 2018.